Cupertino, CA, United States of America

Hongwei Wu

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Hongwei Wu

Introduction

Hongwei Wu is a notable inventor based in Cupertino, California. He has made significant contributions to the field of pharmaceutical compositions, particularly in the treatment of various diseases and conditions. With a total of two patents to his name, his work has the potential to impact many lives.

Latest Patents

Hongwei Wu's latest patents focus on compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25HC3S) or pharmaceutically acceptable salts thereof, combined with at least one cyclic oligosaccharide. These compositions are designed to prevent and treat a variety of diseases, including organ failure, high cholesterol, and various inflammatory conditions. The innovative use of cyclic oligosaccharides, such as cyclodextrins, enhances the efficacy of these compositions.

Career Highlights

Throughout his career, Hongwei Wu has worked with esteemed institutions, including Virginia Commonwealth University and Durect Corporation. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.

Collaborations

Hongwei Wu has collaborated with notable colleagues, including Shunlin Ren and Leyuan Xu. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the development of groundbreaking solutions.

Conclusion

In summary, Hongwei Wu is a distinguished inventor whose work in pharmaceutical compositions holds promise for treating various health conditions. His innovative patents and collaborations reflect his commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…